Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
PersonGen BioTherapeutics’ TAA06 Receives Clinical Trial Approval for B7-H3 CAR-T Therapy
March 3, 2025
Company
Drug
Akeso Biopharma’s Cadonilimab Achieves National Delivery in China
March 3, 2025
Company
Drug
Sobi’s Anakinra (Kineret) Prioritized for Review in China for FMF Treatment
March 3, 2025
Company
Drug
Arctic Vision Enrolls First Patient in ARVN003 Phase III Trial for Presbyopia
March 3, 2025
Policy / Regulatory
Guangdong Releases 2022 Non-Immunization Vaccine Catalog (7th Batch)
March 3, 2025
Company
WuXi Biologics’ MFG14 Facility Approved for Microbial Product Manufacturing
March 3, 2025
Company
Drug
JW Therapeutics Initiates Phase I Study of JWATM204 for Hepatocellular Carcinoma
March 3, 2025
Company
Deals
GenScript Biotech’s ProBio Subsidiary Receives USD 37.25M Investment from Zhenjiang Gaoxin
March 3, 2025
Company
Deals
Zhiyi Bio Raises RMB 100M in Series B++ Round for LBP Pipeline Development
March 3, 2025
Company
Deals
Brii Biosciences Exercises Option for VIR-3434 in Greater China
March 3, 2025
Company
Drug
Innovent Biologics Doses First Patient in IBI112 Phase II Study for Ulcerative Colitis
March 3, 2025
Company
Deals
VivaVision Biotech and Dragon Sail Pharmaceutical Partner on Ophthalmology R & D
March 3, 2025
1
2
…
17
18
19
20
21
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
